TFS International Propels Momentum in Clinical Trials with goBalto
Operational transparency pivotal to process optimization and cycle time reductions
SAN FRANCISCO, March 15, 2018 /PRNewswire/ -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today that TFS International has chosen goBalto's Activate and Analyze solutions for starting clinical trials on a worldwide basis.
Study startup, encompassing activities associated with site identification, feasibility assessment, selection and activation, is a notorious bottleneck in overall study conduct. Numerous factors can adversely impact study startup, such as contract and budget negotiations, regulatory changes and compliance, IRB approvals, clinical staff turnover, and others, contributing to significant trial delays and cost overages.
goBalto's workflow-driven Activate, along with Analyze, a data analytics platform - optimize the many study startup steps, providing real-time insights into study status, making it easier to quantify team performance and discover meaningful patterns in study data.
goBalto Activate guides study teams to complete and track documents, submissions, and other activities required for any site, country, or study based on organizational SOPs and country-specific regulations. Apart from ensuring compliance and streamlining the startup process these custom/study specific workflows capture valuable performance metrics, which in turn allow for benchmarking, descriptive, predicative, and ultimately, prescriptive metrics using goBalto's Analyze – empowering process optimization and effective resource allocation.
Trials generate enormous amounts of data, but stakeholders remain unable to effectively analyze that data to proactively identify risk triggers and operational bottlenecks that can lead to cycle time disruptions and cost overruns. This is inherently due to the way in which performance data is reported and analyzed, relying on antiquated, manually intensive methods like Excel - still predominantly used across the industry - that lack project and risk management functionality.
"Streamlining communications and transparency of activities amongst our clinical operation teams, investigative sites, and sponsor organizations is a central tenet to our corporate strategy of process optimization," said Ed Tumaian, VP Clinical Development, at TFS International. "With the granular level of business intelligence provided by goBalto we are able to make timely interventions and course corrections, as well as uncover insights into processes ripe for future enhancements - ultimately leading to timeline reductions and enhanced operational performance."
"We look forward to supporting TFS International in their strategic goals and to driving value," said Jae Chung, goBalto's Founder and President. "TFS International is tackling this entrenched bottleneck in study conduct head-on to enhance operational efficiencies and speed sought-after therapies to patients in need globally."
About TFS International
TFS International is the leading, mid-size clinical Contract Research Organization (CRO) providing global clinical development solutions. Founded in 1996 in Sweden, TFS currently operates in 21 countries throughout Europe and North America and employs more than 700 professionals. TFS' core therapeutic areas of expertise are Oncology, Dermatology, Ophthalmology, Immunology, Cardiology, CNS and Endocrinology. Through two business areas, TFS DevelopTM and TFS PeopleTM, TFS provides services worldwide as end-to-end solutions or tactical functional services.
About goBalto
goBalto is the industry leader in cloud-based study startup software for the global life sciences industry, offering the only complete end-to-end platform for starting clinical trials, from site identification, feasibility assessment and selection through to activation, with comprehensive metrics to track adherence to timelines and budget. Committed to accelerating clinical trials through innovation, product excellence, and customer success, goBalto works with four of the top five CROs and more than two-thirds of the top 25 pharmas. Our customers include: Allergan, Covance, CMIC HOLDINGS, Genentech Roche, ICON, INC Research, Novartis, PSI CRO, and Worldwide Clinical Trials. goBalto is headquartered in San Francisco, with offices in Philadelphia and Singapore. For more information, visit www.gobalto.com.
Press contact:
Craig Morgan
415.671.4372
[email protected]
SOURCE goBalto, Inc.
Share this article